+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Santen - logo

Santen Pharmaceutical engages in the research, development, manufacture, and marketing of ophthalmic products covering a range of conditions, from allergy and infection to glaucoma. The company offers prescription and over-the-counter products for the treatment of eye and rheumatic diseases. Its products comprise IQUIX, Quixin, Betimo and Alamast. The company was founded in 1890 and is based in Japan.

Keratoconjunctivitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Keratoconjunctivitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • September 2023
  • 745 Pages
  • Global
From
Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • July 2023
  • 229 Pages
  • Global
From
AI Opportunities in Personalised Medicine - Product Thumbnail Image

AI Opportunities in Personalised Medicine

  • Report
  • March 2023
  • Global
From
UK Pharmaceutical Manufacturers & Distributors - Industry Report - Product Thumbnail Image

UK Pharmaceutical Manufacturers & Distributors - Industry Report

  • Report
  • September 2025
  • 550 Pages
  • United Kingdom
From
Canada General Surgical Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Canada General Surgical Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 70 Pages
  • Canada
From
Cell and Gene Therapy market Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change - Product Thumbnail Image

Cell and Gene Therapy market Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change

  • Report
  • June 2021
  • Global
From
North America Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 111 Pages
  • North America
From
Europe Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 119 Pages
  • Europe
From
LAMEA Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 119 Pages
  • Middle East, Africa
From
Asia Pacific Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 119 Pages
  • Asia Pacific
From
Presbyopia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Presbyopia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 68 Pages
  • Global
From
Santen Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Santen Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • September 2025
  • 50 Pages
From
Santen Pharmaceutical Co Ltd (4536) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Santen Pharmaceutical Co Ltd (4536) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • October 2024
  • 65 Pages
From
Loading Indicator